Congress considers biosimilars
The US House of Representatives is considering a bill that would establish a framework for allowing generic biologics to enter the US market
The Pathway for Biosimilars Act was re-introduced this congressional session by US representatives Anna Eshoo, a Democrat from California, Jay Inslee, a Democrat from Washington and Joe Barton, a Republican from Texas.
Generic biologics, or biosimilars, are products that attempt...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.